Research Article

Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy

Table 1

Patients and tumor characteristics.

Characteristics 

Gender
 Male68
 Female74
Tumor location
 Colon6
 Rectum136
Lymph node status
 N050
 N164
 N2, N328
Diagnosis of carcinomatosis
 Synchronous carcinomatosis59
 Metachronous carcinomatosis83
Systemic chemotherapy prior to cytoreduction
 None32
 FOLFOX (+bevacizumab; BV)60 (24)
 FOLFIRI (+BV or +cetuximab)17 (2, 5)
 Xeloda (+oxaliplatin or +BV)17 (14, 5)
 S1 (+paclitaxel)10 (5)
 Others (IRIS#, TJ$, SOX&, and HIPEC¥) 6

IRIS: Irinotecan +S1, $TJ: taxol + CBDCA.
&SOX: S1+ Oxaliplatin.
¥HIPEC: hyperthermic intraperitoneal chemotherapy.